Abstract:Objective: Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow mononuclear cells into the peripheral circulation. Stromal cell-derived factor-1 (SDF-1) enhances the homing of progenitor cells mobilized from the bone marrow and augments neovascularization in ischemic tissue. We hypothesize that SDF-1 will boost the pro-angiogenic effect of G-CSF. Methods and results: NIH 3T3 cells retrovirally transduced with SDF-1 alpha gene (NIH 3T3/SDF-1) were used to deliver SDF-1 in vitro and in vivo. Endothelial progenitor cells (EPCs) co-cultured with NIH 3T3/SDF-1 cells using cell culture inserts migrated faster and were less apoptotic compared to those not exposed to SDF-1. NIH 3T3/SDF-1 (106 cells) were injected into the ischemic muscles immediately after resection of the left femoral artery and vein of C57BL/6J mice. G-CSF (25 mu g/kg/day) was injected intraperitioneally daily for 3 days after surgery. Blood perfusion was examined using a laser Doppler perfusion imaging system. The perfusion ratio of ischemic/non-ischemic limb increased to 0.57 +/- 0.03 and 0.50 +/- 0.06 with the treatment of either SDF-1 or G-CSF only, respectively, 3 weeks after surgery, which was significantly higher than the saline-injected control group (0.41 +/- 0.01, P < 0.05). Combined treatment with both SDF-1 and G-CSF resulted in an even better perfusion ratio of 0.69 +/- 0.08 (P < 0.05 versus the single treatment groups). Mice were sacrificed 21 days after surgery. Immunostaining and Western blot assay of the tissue lysates showed that the injected NIH 3T3/SDF-1 survived and expressed SDF-1. CD34(+) cells were detected with immunostaining, capillary density was assessed with alkaline phosphatase staining, and the apoptosis of muscle cells was viewed using an in situ cell death detection kit. More CD34+ cells, increased capillary density, and less apoptotic muscle cells were found in both G-CSF and SDF-1 treated group (P < 0.05 versus other groups). Conclusion: Combination of G-CSF-mediated progenitor cell mobilization and SDF-1-mediated homing of EPCs promotes neovascularization in the ischemic limb and increases the recovery of blood perfusion. 0 2007 European Society of Cardiology. Published by Elsevier B.V.

Rescuing Impaired Re-endothelialization of Drug-Eluting Stents Using the Hepatocyte Growth Factor.

Sustained Release of Stromal Cell-Derived Factor-1α from Injectable Hydrogels in Combination with Endothelial Progenitor Cells Effectively Promotes Neovascularization in Ischemic Diabetic Rats

Stromal cell-derived factor-1α prevents endothelial progenitor cells senescence and enhances re-endothelialization of injured arteries via human telomerase reverse transcriptase.

Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.

Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor.

Endothelial Progenitor Cells and In-stent Restenosis.

Progress and Prospects of Endothelial Progenitor Cell Therapy in Coronary Stent Implantation

Over-expression of Hepatocyte Growth Factor in Smooth Muscle Cells Regulates Endothelial Progenitor Cells Differentiation, Migration and Proliferation

Effect Of Recombinant Human Sdf-1a On Re-Endothelialization After Sirolimus-Eluting Stent Implantation In Rabbit Aorta Abdominalis

AS-220: Comparison of the Effect of Different Atorvastatin Therapy Doses on Plasma Hepatocyte Growth Factor Concentration in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Infusion of Endothelial Progenitor Cells Accelerates Hematopoietic and Immune Reconstitution, and Ameliorates the Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

Re-Endothelialization Study On Endovascular Stents Seeded By Endothelial Cells Through Up- Or Downregulation Of Vegf

Beneficial Effects Of Granulocyte-Colony Stimulating Factor On Small-Diameter Heparin Immobilized Decellularized Vascular Graft

The Research Progress of Endothelial Progenitor Cell Therapy in Re-endothelialization after Percutaneous Coronary Stent Implantation

Hepatocyte Growth Factor Protects Endothelial Progenitor Cell from Damage of Low-Density Lipoprotein Cholesterol Via the PI3K/Akt Signaling Pathway.

Granulocyte Colony Stimulating Factor for Prevention of Restenosis by Accelerating Endothelial Progenitor Cells Repair

Vegf-Transfected Human Endothelial Cell Coating On Stents Promotes Re-Endothelization And Inhibits In-Stent Restenosis

Hepatocyte Growth Factor Modulates Corneal Endothelial Wound Healing In Vitro

Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.

Development of transgenic endothelial progenitor cell-seeded stents.